JAMA Network Open:饮酒量不同,心血管疾病风险不同

2022-03-29 MedSci原创 MedSci原创

所有饮酒量都与心血管风险增加有关,但不同饮酒量的风险存在显著差异。

观察性研究一贯认为,少量饮酒对心血管有好处,而最近的遗传分析表明,饮酒与心血管疾病风险增加之间可能存在因果关系。然而,传统的遗传流行病学方法假设线性关联,因此没有充分评估不同饮酒水平的风险的剂量反应估计。

Matthew P. Pase等在JAMA Network Open杂志发表题为Association of Neighborhood-Level Socioeconomic Measures With Cognition and Dementia Risk in Australian Adults的研究文章,评估习惯性饮酒与心血管疾病风险的关系,并评估不同饮酒量的心血管疾病风险的方向和相对大小。

该研究采用传统(即线性)和非线性孟德尔随机化方法,评估了饮酒与心血管疾病(如高血压和冠状动脉疾病)之间的潜在关联以及相应的关联形状。饮酒与心血管疾病(包括高血压、冠状动脉疾病、心肌梗死、中风、心力衰竭和房颤)之间的关系。

这项研究包括371463名参与者(平均[SD]年龄57.0[7.9]岁;172 400[46%]男性),他们每周平均饮用9.2(10.6)标准的酒。

121708名参与者(33%)患有高血压。少量至中量饮酒与更健康的生活方式因素相关,调整后减弱了适度饮酒对心脏保护的流行病学相关性

饮酒与心血管疾病表型的遗传关联

饮酒与心血管危险因素的遗传关联

在线性孟德尔随机化分析中,1-SD基因预测的饮酒量增加与高血压风险增高1.3倍(95% CI, 1.2-1.4) (P<0.001)和冠状动脉疾病的风险增高1.4倍(95% CI, 1.1-1.8) (P = 0.006) 相关

非线性孟德尔随机化分析表明,饮酒与高血压和冠状动脉疾病之间存在非线性关联:少量饮酒与心血管疾病风险的最小增加相关,而大量饮酒则与临床和亚临床心血管疾病风险的指数增加相关。

该研究表明所有饮酒量都与心血管风险增加有关,但不同饮酒量的风险存在显著差异

原文出处

Biddinger KJ, Emdin CA, Haas ME, et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Netw Open. 2022;5(3):e223849. doi:10.1001/jamanetworkopen.2022.3849

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729461, encodeId=99e01e2946136, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 29 00:56:01 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734491, encodeId=21321e3449123, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 15 01:56:01 CST 2023, time=2023-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952985, encodeId=da621952985c8, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sun Mar 12 09:56:01 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473327, encodeId=9e5a14e33272e, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499047, encodeId=7504149904ee4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=)]
    2022-09-29 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729461, encodeId=99e01e2946136, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 29 00:56:01 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734491, encodeId=21321e3449123, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 15 01:56:01 CST 2023, time=2023-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952985, encodeId=da621952985c8, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sun Mar 12 09:56:01 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473327, encodeId=9e5a14e33272e, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499047, encodeId=7504149904ee4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=)]
    2023-02-15 canlab
  3. [GetPortalCommentsPageByObjectIdResponse(id=1729461, encodeId=99e01e2946136, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 29 00:56:01 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734491, encodeId=21321e3449123, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 15 01:56:01 CST 2023, time=2023-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952985, encodeId=da621952985c8, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sun Mar 12 09:56:01 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473327, encodeId=9e5a14e33272e, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499047, encodeId=7504149904ee4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=)]
    2023-03-12 huangdf
  4. [GetPortalCommentsPageByObjectIdResponse(id=1729461, encodeId=99e01e2946136, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 29 00:56:01 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734491, encodeId=21321e3449123, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 15 01:56:01 CST 2023, time=2023-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952985, encodeId=da621952985c8, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sun Mar 12 09:56:01 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473327, encodeId=9e5a14e33272e, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499047, encodeId=7504149904ee4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1729461, encodeId=99e01e2946136, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Sep 29 00:56:01 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734491, encodeId=21321e3449123, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 15 01:56:01 CST 2023, time=2023-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952985, encodeId=da621952985c8, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sun Mar 12 09:56:01 CST 2023, time=2023-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473327, encodeId=9e5a14e33272e, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499047, encodeId=7504149904ee4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Mar 28 13:56:01 CST 2022, time=2022-03-28, status=1, ipAttribution=)]

相关资讯

《自然》子刊:大口喝酒,心脏颤抖~~!3.6万人数据分析表明,重要节假日过度饮酒与房颤发作风险增加显著相关

过节期间喝酒时不仅要有肚,还要有度,千万不可一次性暴饮,不然喝酒说不定真成一次性的事儿了。

Am J Clin Nutr:适量饮酒可降低心肌梗死后的长期死亡风险

少量和中等量酒精摄入与稳定心肌梗死后患者的死亡风险呈负相关。

Thyroid:吸烟和饮酒与甲状腺癌风险的关系

该研究观察到甲状腺癌风险与吸烟和饮酒之间呈负相关,这些变量之间存在显著的交互作用。

柳叶刀:一滴酒也致癌!东亚人喝酒患癌率更高

2020年所有新发癌症病例中估计有74万例可归因于饮酒。在男性中,有近57万例酒精引起的癌症病例,在女性中这一数值约为17万。其中肝癌、食管癌和乳腺癌受酒精的影响最多。

转氨酶高一丢丢,过节小酌怡情不要紧?肝病相关死亡风险可升高6倍!

在ALT水平升高的个体中,即使是少量的酒精摄入也与肝脏相关死亡率的增加有关,并且适量的酒精摄入与全因死亡的风险增加有关。

复旦研究:今年想生宝,父亲最晚春节就得戒酒!受孕前父亲喝酒,未来孩子更可能焦虑和调皮......

Scientifc Reports:孕前父亲饮酒和儿童行为问题的风险:前瞻性队列研究